Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

2.

Neutralizing epitopes of human parainfluenza virus type 3 are conformational and cannot be imitated by synthetic peptides.

Henrickson KJ, Kingsbury DW, van Wyke Coelingh KL, Naeve CW, Portner A.

Vaccine. 1991 Apr;9(4):243-9.

PMID:
1711742
3.
4.

Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system.

Giese N, May-Siroff M, LaRochelle WJ, van Wyke Coelingh K, Aaronson SA.

J Virol. 1989 Jul;63(7):3080-6.

6.
7.

Posttranslational processing of endogenous and of baculovirus-expressed human gastrin-releasing peptide precursor.

Lebacq-Verheyden AM, Kasprzyk PG, Raum MG, Van Wyke Coelingh K, Lebacq JA, Battey JF.

Mol Cell Biol. 1988 Aug;8(8):3129-35.

8.

Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.

Murphy BR, Prince GA, Collins PL, Van Wyke Coelingh K, Olmsted RA, Spriggs MK, Parrott RH, Kim HW, Brandt CD, Chanock RM.

Virus Res. 1988 Aug;11(1):1-15. Review.

PMID:
2845680
9.

Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge.

van Wyke Coelingh KL, Winter CC, Tierney EL, London WT, Murphy BR.

J Infect Dis. 1988 Apr;157(4):655-62.

PMID:
2831282
10.
11.

Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus.

van Wyke Coelingh KL, Murphy BR, Collins PL, Lebacq-Verheyden AM, Battey JF.

Virology. 1987 Oct;160(2):465-72.

PMID:
2821684
13.

Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus.

van Wyke Coelingh KL, Winter C, Murphy BR.

Virology. 1985 Jun;143(2):569-82.

PMID:
2414910

Supplemental Content

Loading ...
Support Center